Zhejiang Excel Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is GEMFIBROZIL USP, with a corresponding US DMF Number 19407.
Remarkably, this DMF maintains an Active status since its submission on June 13, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 22, 2019, and payment made on August 20, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II